Treatment
Treatment A clinical trials
We’re tracking 8,310 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT07590115Enrolling by invitation
Behavioral Patterns and Treatment Success in Substance Use Recovery
This study looks at how behavioral patterns change during residential treatment for substance use disorder. Researchers will track your progress over several weeks to understand what helps people succeed in recovery.
Potrerillos, JaliscoAges 18–60 - NCT07594691Recruiting
Breath-Hold Techniques to Improve Radiation Therapy Accuracy
This trial tests whether holding your breath during imaging scans can help doctors aim radiation therapy more precisely at upper abdominal cancers while protecting nearby healthy organs. The goal is to reduce side effects by improving treatment accuracy.
Toronto, OntarioAges 18 years+ - NCT07591857Recruiting
Computer-Based Brain Training for Cancer-Related Memory Loss
This study tests whether a computer-based brain training program delivered in a group setting can help women who experienced memory or thinking problems after breast cancer treatment. The program is designed to retrain and improve how your brain processes information.
JerusalemAges 18 years+ - NCT06433271Recruiting
Therapy study for adjustment disorder after trauma
This study compares a new type of talk therapy (Transdiagnostic Behavior Therapy) to standard care for veterans and active military members who are struggling with adjustment disorder after a traumatic event. The goal is to see which approach helps people feel better and adjust to life after trauma.
Charleston, South CarolinaAges 18 years+ - NCT06720558Recruiting
Placebo probiotic effects on gut health in mild GI symptoms
This study tests whether a placebo probiotic can improve gut health and overall well-being in people with mild digestive issues like gas, bloating, or irregularity. If you have mild symptoms that don't stop your daily activities, this trial may help understand if believing you're taking a probiotic can make you feel better.
MilanAges 20–65 - NCT06720324RecruitingPhase 1/Phase 2
CD7-targeted CAR-T therapy for relapsed blood cancers
This trial tests a new type of immune cell therapy (CAR-T cells) that targets a specific marker called CD7 on blood cancer cells. It is for people whose blood cancer has not responded to other treatments or has come back after treatment.
Wuhan, HubeiAges 3–75 - NCT06720831Recruiting
Mesh vs no mesh for prolapse surgery
This trial compares two types of laparoscopic surgery for female genital prolapse — one using a mesh and one without. It aims to see which approach works better and is safer for women needing this operation.
Bologna, BolognaAges 18–80 - NCT05500963Recruiting
TENS to reduce fatigue in relapsing-remitting multiple sclerosis
This study tests whether TENS, a non-drug device that delivers mild electrical signals through the skin, can reduce fatigue in people with relapsing-remitting multiple sclerosis (MS). It also includes an exercise-training portion and checks safety and comfort during the program.
Boulder, ColoradoAges 18–65 - NCT05423275Recruiting
Light treatment to help you stop antidepressants safely
This study tests whether a “light and ion” treatment can help people with major depression (MDD) who are doing well on antidepressants safely reduce or stop them. You must be in remission and be willing to discontinue for reasons like side effects or personal preference.
Vancouver, British ColumbiaAges 19–65 - NCT05899140RecruitingPhase 4
Clindamycin added to treat certain skin infections
This trial tests whether adding clindamycin helps treat skin and soft-tissue infections caused by Staphylococcus aureus. You may be eligible if your infection was diagnosed recently and a sample was collected soon after hospital admission.
MasokoriAges 18 years+ - NCT06427577Recruiting
Study of ZhenQiFuZheng for allergic rhinitis
This trial tests if a traditional Chinese medicine called ZhenQiFuZheng can help people with allergic rhinitis by changing their gut bacteria. Researchers will collect samples to understand how it works.
Nanjing, JiangsuAges 18–65 - NCT07583849RecruitingPhase 3
Testing a new inhaled powder for COPD symptoms
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
Beijing, Beijing MunicipalityAges 40–80 - NCT07586124RecruitingPhase 2
Immunotherapy plus antibody drug for advanced head and neck cancer
This trial tests a combination of two drugs (pucotenlimab and becotatug vedotin) given before surgery for advanced head and neck squamous cell carcinoma. The goal is to shrink tumors and improve outcomes when combined with surgery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07582315RecruitingPhase 3
BL-B01D1 for advanced biliary tract cancer after prior treatments
This study tests a new drug called BL-B01D1 against standard treatment options for patients with advanced biliary tract cancer (cancer of the bile ducts) that has stopped responding to platinum chemotherapy and immunotherapy. The drug is designed to target and destroy cancer cells more effectively.
Beijing, Beijing MunicipalityAges 18–75 - NCT07582783Recruiting
Treatment Persistence with Guselkumab for Moderate-to-Severe Plaque Psoriasis
This study tracks how well patients stick with guselkumab, a biologic injection medication for moderate-to-severe plaque psoriasis. Researchers want to understand real-world treatment outcomes in Romania to help improve psoriasis care.
BârladAges 18 years+ - NCT07585097Recruiting
Long-term Safety Study of Odevixibat for Alagille Syndrome
This study follows patients with Alagille syndrome who are taking odevixibat to see how safe the medicine is over time. Alagille syndrome is a rare liver disease that affects bile flow, and odevixibat is a treatment that may help reduce itching and improve liver function.
BronAges 6 months+ - NCT07584135RecruitingPhase 3
JS107, Toripalimab, and Chemotherapy for Advanced Stomach Cancer
This study tests a combination of three treatments—JS107, toripalimab (an immunotherapy), and chemotherapy—for advanced stomach cancer that has a specific protein marker called CLDN18.2. The goal is to see if this combination can shrink tumors and help patients live longer.
Guangzhou, GuangdongAges 18 years+ - NCT07585968Recruiting
New Catheter Treatment for Dangerous Heart Rhythms
This trial tests a new catheter-based procedure to treat life-threatening irregular heartbeats (ventricular tachycardia) that keep coming back despite medication. If you've had a heart attack and your implanted defibrillator hasn't fully controlled these arrhythmias, this procedure might help prevent future episodes.
Indianapolis, IndianaAges 18–85 - NCT07584954RecruitingPhase 1
Testing a new cancer immunotherapy in advanced solid tumors
This Phase 1 trial tests a new drug called IUAb190708 designed to help your immune system fight advanced or recurrent solid cancers. The study will evaluate its safety, how your body handles it, and whether it works against your tumor.
Fuzhou, FujianAges 18–75 - NCT07585981Recruiting
Budesonide capsules for IgA kidney disease
This trial tests whether a special steroid capsule called budesonide can help treat IgA nephropathy, a kidney disease where your immune system damages the kidneys. You would take this medication along with standard care to see if it slows kidney damage and reduces protein in your urine.
BeijingAges 18 years+ - NCT07583810RecruitingPhase 2
Nemtabrutinib and Rituximab for Marginal Zone Lymphoma
This trial tests a combination of two drugs—nemtabrutinib (a BTK inhibitor that targets cancer cells) and rituximab (an antibody drug)—to treat marginal zone lymphoma, a type of blood cancer. The study aims to see if this combination works better than standard treatments.
Duarte, CaliforniaAges 18 years+ - NCT07579962RecruitingPhase 2
Bleomycin with electrical current for low-flow vascular malformations
This study tests a treatment called bleomycin electrosclerotherapy (BEST) for people with low-flow vascular malformations—abnormal clusters of blood or lymph vessels that can cause pain or swelling. The treatment combines a drug (bleomycin) with a small electrical current to shrink these abnormal vessels, and the goal is to see if it helps when other treatments haven't worked well or the problem came back.
LjubljanaAges 18–99 - NCT07579442Recruiting
Narrative writing therapy for young people with anorexia nervosa
This study tests a virtual group program where young people with anorexia nervosa use reflective writing and discussion to explore their experiences. It may help you feel more connected and supported in your recovery journey.
San Francisco, CaliforniaAges 16–25 - NCT07585045Recruiting
Magnesium Supplements for Fibromyalgia Not Helped by Standard Drugs
This study tests whether taking magnesium by mouth can reduce fibromyalgia pain in people whose symptoms don't improve with common medications like amitriptyline, duloxetine, or pregabalin. Magnesium is a mineral that may help relax muscles and ease pain.
Lahore, Punjab ProvinceAges 18–65
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,310 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.